IGF1R and cholangiocarcinoma: To escape tumor treatment, the upregulated insulin receptor (IR) and insulin-like growth factor (IGF) 1 receptor (IGF1R) in cholangiocarcinoma (CCA) cancer cells promote the proliferation and activation of CAFs.